People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| X-Biotix Therapeutics, Inc. | — | Biotechnology | Series A | $13.4M | $145.0M | 2018 |
Thomas G. Bernhardt Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas G. Bernhardt Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen T. Isaacs | 1 | 2 |
| Christopher D. Ray | 1 | 2 |
| Ramani Varanasi | 1 | 1 |
| David D. Cook, Ph.D. | 1 | 1 |
| Dominic D. Ryan | 1 | 1 |
| M. Dominic Ryan Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.